Skip to content

Safer injecting practices would be better promoted by focusing on pleasure and practical concerns – not the risk of infection

Sofosbuvir/ledipasvir with ribavirin cures most people with hepatitis C recurrence after liver transplantation

Sofosbuvir + simeprevir shows good results for hepatitis C in real-world use

Donald Jensen speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.

HIV epidemic will spring back without near-universal diagnosis and treatment, says UNAIDS

British HIV cure survey: most respondents would be prepared to take some health risk to help find a cure for HIV

DAAs show good cure rates and liver function improvement for transplant recipients with recurrent HCV

Robert Brown speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.

AbbVie 3D regimen cures recurrent HCV in most liver transplant recipients without cirrhosis

Parvez Mantry speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.

NHS urgently needs to make PrEP available, say HIV prevention organisations

NHS urgently needs to make PrEP available, say HIV prevention organisations

Tenofovir continues to suppress hepatitis B virus for eight years